Grants per year
Personal profile
Education/Academic qualification
Bioinorganic Chemistry, PhD, Columbia University
… → 1985
Bioinorganic Chemistry, MA, University of Missouri, Columbia
… → 1980
Chemistry, BS, University of Missouri, Columbia
… → 1979
Fingerprint Dive into the research topics where Thomas V O'Halloran is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Copper
Medicine & Life Sciences
Zinc
Medicine & Life Sciences
Metals
Medicine & Life Sciences
Metallochaperones
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Ions
Medicine & Life Sciences
Superoxide Dismutase
Medicine & Life Sciences
Platinum
Chemical Compounds
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 1998 2022
Mechanisms of Cadmium Induced Dysglycemia and Type 2 Diabetes Mellitus
Allen, N. B., El Muayed, M. & O'Halloran, T. V.
National Institute of Environmental Health Sciences
9/15/17 → 5/31/22
Project: Research project
Cadmium
Type 2 Diabetes Mellitus
Insulin
Prediabetic State
Reticulum
Metalloregulation by MerR and Fur Protein Families
Bleher, R. & O'Halloran, T. V.
National Institute of General Medical Sciences
1/1/17 → 11/30/20
Project: Research project
Metals
Physiology
Proteins
Metal ions
Escherichia coli
Dr. Woodruff's Subproject for Regulatory Roles of Zinc Fluxes in Metalloprotein Occupancy and Cell Cycle Progression
O'Halloran, T. V., Woodruff, T. K. & Woodruff, T. K.
National Institute of General Medical Sciences
7/1/15 → 4/30/20
Project: Research project
Metalloproteins
Zinc
Cell Cycle
Proteins
Metals
Regulatory Roles of Zinc Fluxes in Metalloprotein Occupancy and Cell Cycle Progression
National Institute of General Medical Sciences
7/1/15 → 4/30/20
Project: Research project
Metalloproteins
Zinc
Cell Cycle
Proteins
Metals
Oncology
Research Output 1978 2019
1
Citation
(Scopus)
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent
Miodragović, D., Merlino, A., Swindell, E. P., Bogachkov, A., Ahn, R. W., Abuhadba, S., Ferraro, G., Marzo, T., Mazar, A. P., Messori, L. & O'Halloran, T. V., Apr 24 2019, In : Journal of the American Chemical Society. 141, 16, p. 6453-6457 5 p.Research output: Contribution to journal › Article
Antineoplastic Agents
DNA
Arsenic
Cisplatin
Tumors
Bovine eggs release zinc in response to parthenogenetic and sperm-induced egg activation
Que, E. L., Duncan, F. E., Lee, H. C., Hornick, J. E., Vogt, S., Fissore, R. A., O'Halloran, T. V. & Woodruff, T. K., Mar 15 2019, In : Theriogenology. 127, p. 41-48 8 p.Research output: Contribution to journal › Article
Eggs
Ovum
Spermatozoa
Zinc
zinc
Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity
Johnson, S. E., Ugolkov, A., Haney, C. R., Bondarenko, G., Li, L., Waters, E. A., Bergan, R., Tran, A., O'Halloran, T. V., Mazar, A. & Zhao, M., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1331-1342 12 p.Research output: Contribution to journal › Article
Whole Body Imaging
Drug-Related Side Effects and Adverse Reactions
Cell Death
Drug Therapy
Toxicology
2
Citations
(Scopus)
9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma
Ugolkov, A. V., Bondarenko, G. I., Dubrovskyi, O., Berbegall, A. P., Navarro, S., Noguera, R., O'Halloran, T. V., Hendrix, M. J., Giles, F. J. & Mazar, A. P., Sep 1 2018, In : Anti-Cancer Drugs. 29, 8, p. 717-724 8 p.Research output: Contribution to journal › Article
Glycogen Synthase Kinase 3
Neuroblastoma
irinotecan
Heterografts
Pediatrics
1
Citation
(Scopus)
Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
Ugolkov, A. V., Matsangou, M., Taxter, T. J., O'Halloran, T. V., Cryns, V. L., Giles, F. J. & Mazar, A. P., Nov 1 2018, In : Oncology Letters. 16, 5, p. 6437-6444 8 p.Research output: Contribution to journal › Article
Glycogen Synthase Kinase 3
Head and Neck Neoplasms
Breast Neoplasms
Breast
Protein-Serine-Threonine Kinases